Kruppel-like factor 4 (KLF-4) inhibits the epithelial-to-mesenchymal transition and proliferation of human endometrial carcinoma cells
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Kruppel-like factor 4 (KLF-4) inhibits the epithelial-to-mesenchymal transition and proliferation of human endometrial carcinoma cells
Authors
Keywords
-
Journal
GYNECOLOGICAL ENDOCRINOLOGY
Volume 32, Issue 9, Pages 772-776
Publisher
Informa UK Limited
Online
2016-04-21
DOI
10.3109/09513590.2016.1163673
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Downregulation of the KLF4 transcription factor inhibits the proliferation and migration of canine mammary tumor cells
- (2015) Yung-Tien Tien et al. VETERINARY JOURNAL
- Krüppel-like factor 4 induces apoptosis and inhibits tumorigenic progression in SK-BR-3 breast cancer cells
- (2015) Bing Wang et al. FEBS Open Bio
- Krüppel-like factor 4 mediates anti-proliferative effects of progesterone with G0/G1 arrest in human endometrial epithelial cells
- (2014) Y. Shimizu et al. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
- Oxidative DNA damage causes premature senescence in mouse embryonic fibroblasts deficient for Krüppel-like factor 4
- (2014) Changchang Liu et al. MOLECULAR CARCINOGENESIS
- Doxycycline Inducible Kruppel-Like Factor 4 Lentiviral Vector Mediates Mesenchymal to Epithelial Transition in Ovarian Cancer Cells
- (2014) Zixuan Chen et al. PLoS One
- Kruppel-like factor 4 blocks tumor cell proliferation and promotes drug resistance in multiple myeloma
- (2013) M. Schoenhals et al. HAEMATOLOGICA
- E-cadherin-integrin crosstalk in cancer invasion and metastasis
- (2013) M. Canel et al. JOURNAL OF CELL SCIENCE
- ZEB1 overexpression associated with E-cadherin and microRNA-200 downregulation is characteristic of undifferentiated endometrial carcinoma
- (2013) Laura Romero-Pérez et al. MODERN PATHOLOGY
- Krüppel-like factor 4 regulates genetic stability in mouse embryonic fibroblasts
- (2013) Enas A El-Karim et al. Molecular Cancer
- Attenuation of Krüppel-Like Factor 4 Facilitates Carcinogenesis by Inducing G1/S Phase Arrest in Clear Cell Renal Cell Carcinoma
- (2013) Erlin Song et al. PLoS One
- Intratumoral α-SMA Enhances the Prognostic Potency of CD34 Associated with Maintenance of Microvessel Integrity in Hepatocellular Carcinoma and Pancreatic Cancer
- (2013) Wen-Quan Wang et al. PLoS One
- The EMT signaling pathways in endometrial carcinoma
- (2012) Eva Colas et al. Clinical & Translational Oncology
- The Ins and Outs of the Epithelial to Mesenchymal Transition in Health and Disease
- (2011) M. Angela Nieto Annual Review of Cell and Developmental Biology
- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Tumor budding and E-Cadherin expression in endometrial carcinoma: Are they prognostic factors in endometrial cancer?
- (2011) Meral Koyuncuoglu et al. GYNECOLOGIC ONCOLOGY
- KLF4 inhibition of lung cancer cell invasion by suppression of SPARC expression
- (2010) Yanbin Zhou et al. CANCER BIOLOGY & THERAPY
- Expression of the Tumor Suppressor Kruppel-Like Factor 4 as a Prognostic Predictor for Colon Cancer
- (2010) N. V. Patel et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Growth Factors in Induction of Epithelial-Mesenchymal Transition and Metastasis
- (2010) Nur Akmarina B.M. Said et al. CELLS TISSUES ORGANS
- Mammalian Krüppel-Like Factors in Health and Diseases
- (2010) Beth B. McConnell et al. PHYSIOLOGICAL REVIEWS
- Krüppel-like factor 4 represses transcription of the survivin gene in esophageal cancer cell lines
- (2009) Guo Zhang et al. BIOLOGICAL CHEMISTRY
- KLF4 gene expression is inhibited by the notch signaling pathway that controls goblet cell differentiation in mouse gastrointestinal tract
- (2008) Hai Zheng et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started